- Home
- BMRN vs CTRE Comparison
BMRN vs CTRE Comparison
Compare BMRN & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | CTRE |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.2B |
| IPO Year | 1999 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BMRN | CTRE |
|---|---|---|
| Price | $63.10 | $40.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 9 |
| Target Price | ★ $90.10 | $42.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.8M |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | ★ 154.02 | 96.25 |
| EPS | ★ 2.04 | 1.57 |
| Revenue | ★ $1,313,646,000.00 | $476,393,000.00 |
| Revenue This Year | $13.53 | $7.12 |
| Revenue Next Year | $10.40 | $14.62 |
| P/E Ratio | $31.09 | ★ $25.44 |
| Revenue Growth | 17.62 | ★ 60.79 |
| 52 Week Low | $50.76 | $24.90 |
| 52 Week High | $73.51 | $41.36 |
Technical Indicators
Market Signals| Indicator | BMRN | CTRE |
|---|---|---|
| Relative Strength Index (RSI) | 72.31 | 61.12 |
| Support Level | $59.38 | $39.22 |
| Resistance Level | $63.75 | $41.36 |
| Average True Range (ATR) | 1.93 | 0.94 |
| MACD | 0.55 | 0.19 |
| Stochastic Oscillator | 94.59 | 73.78 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.